Lakefront Biotherapeutics LKFT
NASDAQ LKFT
$30.65 -0.10 (-0.33%)
As of: Oct 21, 2026 · 2:24 PM EDT

Lakefront Biotherapeutics (LKFT) Deferred Taxes (2017)

Updated

Lakefront Biotherapeutics' Deferred Taxes came in at -$420,290 for the year ended Dec 31, 2025, compared with $439,429 a year earlier.

Analysis

Lakefront Biotherapeutics (LKFT) Deferred Taxes (2017) Analysis & Trends

Going back to the year ended Dec 31, 2015, Lakefront Biotherapeutics' Deferred Taxes data covers 11 years.

  • The five-year range for annual Deferred Taxes is -$8.79 million (the year ended Dec 31, 2023) to $439,429 (the year ended Dec 31, 2024).
  • Per Business Quant, earlier years put Deferred Taxes at $439,429 in the year ended Dec 31, 2024, -$8.79 million in the year ended Dec 31, 2023, -$4.67 million in the year ended Dec 31, 2022 and -$809,444 in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,135.59 Bn 1,104.17 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 616.92 Bn 535.45 Bn 17.26 Bn -479.00 Mn
3 AbbVie 501.52 Bn 474.63 Bn 12.70 Bn -195.00 Mn
4 Merck 367.36 Bn 321.74 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 297.93 Bn 261.92 Bn 11.24 Bn -
6 Astrazeneca 261.45 Bn 235.14 Bn 12.86 Bn -
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 190.72 Bn 164.92 Bn 6.22 Bn -587.00 Mn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn -1.32 Bn
10 Lakefront Biotherapeutics 2.02 Bn 2.02 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -213,115.29
API Access

Lakefront Biotherapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=LKFT&period=max&api_key=YOUR_API_KEY